Topical Insulin for Open-Angle Glaucoma

This trial tests eye drops made from insulin to determine their safety and effectiveness for people with open-angle glaucoma, a common eye condition that can lead to vision loss. The study examines different doses to identify the most effective one while monitoring for side effects. Individuals with open-angle glaucoma who have one eye with worse vision might be suitable candidates for this trial. As a Phase 1/Phase 2 trial, the research aims to understand how the treatment works in people and measure its effectiveness in an initial group, offering participants a chance to be among the first to benefit from this innovative approach.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team to get a clear answer.

Research has shown that insulin eye drops, such as EYED-002, are generally safe for treating open-angle glaucoma. Studies have found that both low and high doses are well-tolerated. The most common side effect is a mild, temporary stinging sensation after use. Importantly, no serious side effects have been reported. Additionally, studies with doses up to 500 units per milliliter have shown no major problems with short-term use. This safety information suggests that insulin eye drops for glaucoma could be a promising and safe treatment option.¹²³⁴⁵

Unlike the standard treatments for open-angle glaucoma, which often involve eye drops to lower eye pressure, the investigational treatment EYED-002 uses topical insulin. Researchers are excited about this approach because insulin has unique properties that may protect and regenerate nerve cells in the eye, potentially addressing the disease's root cause rather than just the symptoms. Additionally, this treatment is delivered through eye drops, making it a familiar and non-invasive option for patients, with the potential to show results in just a few days.

This trial will evaluate the effects of topical insulin eye drops, EYED-002, for treating open-angle glaucoma. Participants will join different groups to receive either low-dose, high-dose, or the highest tolerated dose of EYED-002 for an extended period. Research has shown that insulin eye drops might help treat open-angle glaucoma by focusing on nerve health rather than just reducing eye pressure. Studies have found that these drops are generally safe and well-tolerated, even at higher doses, with no serious eye-related side effects. Early results suggest that insulin may help heal eye tissues, offering promise for people with glaucoma. While researchers are still studying the exact effects on vision, the potential to improve eye structure and function makes this an exciting area of research.¹²³⁵⁶